Latest CellaVision News & Updates
See the latest news and media coverage for CellaVision. We track all announcements, press releases, and industry mentions in real time, all in one place.
Digital hematology microscopy solutions provider
cellavision.com- Headquarters
- Lund, Sweden
- Founded year
- 1994
- Company type
- Public company
- Number of employees
- 250–500
Last updated
Latest news about CellaVision
In short: CellaVision reported a weaker first quarter for 2026 and announced key leadership changes including a new Chairman and a permanent CFO.
Company announcements
-
CellaVision launches Bone Marrow Aspirate Application
It enables collaboration on analysis to share expertise and reduce variability. Available in CE-marked markets under EU IVDR; not FDA-approved.
-
CellaVision holds Annual General Meeting
Resolutions approve financial statements, dividend of SEK 2.75 per share, board elections with Zlatko Rihter as new Chairman, and share repurchase authorization.
-
CellaVision releases Q1 2026 interim report
Report shows softer quarter from lower EMEA sales. They launched CE-marked Bone Marrow Aspirate Application and software upgrade.
-
CellaVision reports softer Q1 2026 quarter
Organic sales growth was -6.6%; EBITDA margin 24%. Net sales fell 14.6% to SEK 166m.
Media coverage
-
CellaVision: Bulletin from the Annual General Meeting of CellaVision AB (publ)
The following resolutions were passed at the Annual General Meeting (the "AGM") of CellaVision AB (publ) on 28 April 2026 in Lund.Adoption of profit and...
-
Revenue decline from Cellavision - profit decreased
Cellavision, which operates in systems for automatic image analysis of blood and other body fluids, reports an ebitda result of 40 million kronor...
-
Nomination Committee's proposal for the 2026 annual general meeting in CellaVision AB | Placera.se
The Nomination Committee in CellaVision AB (publ) ("CellaVision" or "the Company") hereby announces the Nomination Committee's proposal to the annual general meeting regarding the number of board members, election of board members, election of Chairman of the Board and board fees.
-
Nordea lowers the target price for Cellavision to 228 kronor (230), repeats buy
By subscribing to the free subscription Affärsvärlden Free, you get a selection of all our material, as well as a daily newsletter with the latest news.
Track CellaVision and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
CellaVision competitors & trending companies
Browse news for competitors to CellaVision and other trending companies.
Boule Diagnostics
Pit
Davis AI
Qutwo
DigiPowerX
Penguin Solutions
Sterling Infrastructure
KIOXIA Corporation
Subquadratic
Tibber
IREN
A24
Hitachi Energy
Ouster
Ormat Technologies
Fabrinet
AOI
WidePoint
Filtronic
Mirum Pharmaceuticals
Capstone Green Energy
AXT
POET Technologies
PurpleFire
Profitable Media
Sironax
Aperture Therapeutics
Attentive
Klaviyo
Twilio
Insider One
Zeta Global
Iterable
Braze
Optimove